Deep Learning to Estimate RECIST in Patients with NSCLC Treated with PD-1 Blockade-Reference-Cited by-同舟云学术

Deep Learning to Estimate RECIST in Patients with NSCLC Treated with PD-1 Blockade

Published:2020-09-21 Issue:1 Volume:11 Page:59-67
ISSN:2159-8274
Container-title:Cancer Discovery
language:en
Short-container-title:Cancer Discov

Author:

Arbour Kathryn C.^ORCID,Luu Anh Tuan,Luo Jia^ORCID,Rizvi Hira,Plodkowski Andrew J.^ORCID,Sakhi Mustafa^ORCID,Huang Kevin B.^ORCID,Digumarthy Subba R.^ORCID,Ginsberg Michelle S.,Girshman Jeffrey^ORCID,Kris Mark G.,Riely Gregory J.,Yala Adam^ORCID,Gainor Justin F.,Barzilay Regina,Hellmann Matthew D.^ORCID

Funder

Memorial Sloan Kettering Cancer Center Support Grant

Memorial Sloan Kettering Cancer Center

NIHConquer Cancer FoundationAmerican Society of Clinical OncologyConquer Cancer FoundationAmerican Society of Clinical Oncology

Damon Runyon Cancer Research Foundation

Publisher

American Association for Cancer Research (AACR)

Subject

Oncology

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Extracting Systemic Anticancer Therapy and Response Information From Clinical Notes Following the RECIST Definition;JCO Clinical Cancer Informatics;2024-06

2. Artificial intelligence to unlock real‐world evidence in clinical oncology: A primer on recent advances;Cancer Medicine;2024-06

3. Artificial Intelligence and Machine Learning in Predicting the Response to Immunotherapy in Non-small Cell Lung Carcinoma: A Systematic Review;Cureus;2024-05-28

4. Biomarkers and computational models for predicting efficacy to tumor ICI immunotherapy;Frontiers in Immunology;2024-03-08

5. Advancing equitable and personalized cancer care: Novel applications and priorities of artificial intelligence for fairness and inclusivity in the patient care workflow;European Journal of Cancer;2024-02